Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer.

International journal of oncology

Volumn 17, Issue 6, 2000, Pages 1107-1118

  Araki, K ^a   Noguchi, Y ^a   Hirouchi, T ^a   Yoshikawa, E ^a   Kataoka, S ^a   Silverni, L ^a   Miyazawa, H ^a   Kuzuhara, H ^a   Suzuki, C ^a   Shimada, Y ^a   Hamasato, S ^a   Maeda, N ^a   Shimamura, Y ^a   Ogawa, Y ^a   Ohtsuki, Y ^a   Fujimoto, S ^a  

^a Kochi shi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CANCER VACCINE; HLA ANTIGEN; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CELL CULTURE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; EVALUATION; FEMALE; GENETICS; HAPLOTYPE; HUMAN; IMMUNIZATION; IMMUNOLOGY; JAPAN; LEUKAPHERESIS; MALE; MIDDLE AGED; NEOPLASM; PATHOLOGY; REMISSION; RETROSPECTIVE STUDY; TRANSPLANTATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANTIGENS, NEOPLASM; CANCER VACCINES; CELLS, CULTURED; FEMALE; HAPLOTYPES; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOTHERAPY, ADOPTIVE; ISOANTIGENS; JAPAN; LEUKAPHERESIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0034547826     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.6.1107     Document Type: Article

References (0)